ApolloMed Q1 revenue up 50% to $263M; raises FY guidance; appoints new CFO

Astrana Health, Inc.

2022-Q1 EPS reported $0.31 revenue$263,258,000

Q1 revenue $263.3M, up 50% YoY; net income attributable to ApolloMed $14.3M (+8%); adj. EBITDA $38.2M (+25%).
FY guidance raised: revenue $1,055M–$1,085M; adj. EBITDA $136M–$166M (previous low $130M).
CFO Eric Chin steps down for personal reasons; Chan Basho appointed Interim CFO and Chief Strategy Officer.
Basho's compensation: $300k base, $200k sign-on bonus, $1.2M initial restricted stock award.
Completed acquisition of Jade Health Care Medical Group, adding ~13,000 Medicare/Medicaid members.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Eric Chin

Chief Financial Officer

ASTH · Astrana Health, Inc.

Effective: 2022-05-05
Successor: Chan Basho
Filed: May 5, 2022, 7:59 PM ET

In connection with the appointment, Eric Chin will step down for personal reasons as Chief Financial Officer effective May 5, 2022.

Appointed (interim)

Chan Basho

Interim Chief Financial Officer

ASTH · Astrana Health, Inc.

Effective: 2022-05-05
Filed: May 5, 2022, 7:59 PM ET

On May 5, 2022, the Company appointed Chan Basho as the Company's Interim Chief Financial Officer, effective May 5, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Chin departed as Chief Financial Officer at Astrana Health, Inc..

Action: stepped down
Role: Chief Financial Officer

Exact text from the filing

In connection with the appointment, Eric Chin will step down for personal reasons as Chief Financial Officer effective May 5, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Chan Basho was appointed as Interim Chief Financial Officer at Astrana Health, Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On May 5, 2022, the Company appointed Chan Basho as the Company's Interim Chief Financial Officer, effective May 5, 2022.

View on SEC.gov

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-012666

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.